Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ETNew detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Teva's long haul to a turnaround of its business has been dealt a blow by the FDA, which has just declined to approve the company's long-acting formulation of schizophrenia drug risperidone.

Efter våldsdådet på Campus Risbergska skolan i Örebro den 4 februari samlades hela Sverige till stöd för de drabbade. Statsministern bjöd in till en nationell tyst minut för att hedra offren, och ...

De båda ministrarna undertecknade en avsiktsförklaring för att ta vidare arbetet med den strategiska partnerskapsöverenskommelsen mellan Sverige och Polen. Carl-Oskar Bohlin och Gunnar Strömmer tar ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: 7:55:40 p.m. EST Loading Chart for TEVA ...